Skip to main content
Human Reproduction (Oxford, England) logoLink to Human Reproduction (Oxford, England)
. 2018 Dec 6;34(2):388. doi: 10.1093/humrep/dey363

Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Helena J Teede 1,2,3,, Marie L Misso 1,2,3, Michael F Costello 4, Anuja Dokras 5, Joop Laven 6, Lisa Moran 1,2,3, Terhi Piltonen 7, Robert J Norman 1,2,8; International PCOS Network
PMCID: PMC6343464  PMID: 30521039

Hum Reprod 2018;33:1602–1618

The journal, Human Reproduction, would like to apologise for an error under the sub-section Biochemical hyperandrogenism of Table III in the above article. The following statement:

Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time.

Should read:

Where assessment of biochemical hyperandrogenism is important in women on hormonal contraception, drug withdrawal is recommended for 3 months or longer before measurement, and contraception management with a non-hormonal alternative is needed during this time.

The electronic version of this article has been updated at https://doi.org/10.1093/humrep/dey256. The Journal would like to assure readers that this does not affect any other content of the article.


Articles from Human Reproduction (Oxford, England) are provided here courtesy of Oxford University Press

RESOURCES